[Muscular dystrophy as a risk factor in anesthesia].
Three cases of muscular dystrophy are reported on (8 years, 4 months, 10 months) in which serious conditions arose under anaesthetic (bradycardia, asystolia, hyperkalemia, rising CPK). In the first two cases there was no way of avoiding a fatal outcome, but in the third case the child survived with no permanent damage. The cause of incidents of this kind is discussed first as being hyperkalemia due to acute rhabdomyolysis, and secondly malign hyperthermia. There were no indications of malign hyperthermia in this case. It is hardly possible to distinguish this in an acute clinical ward, as the clinical symptoms are very similar. If it is known that muscular dystrophy is present, depolarising relaxants should be given sparingly. This also applies, as the first case shows, for muscular dystrophy of the Becker type, which can on the whole be regarded as benign in comparison with progressive muscular dystrophy of the Duchenne type. In this instance a forensic and anaesthetic expert's opinion even had to be produced at the request of the Public Prosecutor. The post mortem was carried out under the heading of a possible "mistaken medical treatment" but there was no evidence to justify such an assumption.
Schneider
V
V
Institut für Rechtsmedizin, Freien Univ., Berlin.
Eyrich
K
K
Stelzner
J
J
D000768:Anesthesia, General; D001706:Biopsy; D002648:Child; D006801:Humans; D007223:Infant; D008297:Male; D008305:Malignant Hyperthermia / Q000235:genetics / Q000473:pathology / Q000503:physiopathology*; D008318:Malpractice / Q000331:legislation & jurisprudence; D009132:Muscles / Q000473:pathology; D009136:Muscular Dystrophies / Q000235:genetics / Q000473:pathology / Q000503:physiopathology*; D012307:Risk Factors; D013390:Succinylcholine / Q000008:administration & dosage / Q000009:adverse effects*
D013390:Succinylcholine
Die Muskeldystrophie als Anästhesie-Risiko.